Novartis Ag Adr (NVS)

Aug 07, 2025

What’s Next for Pharma Stocks After Trump’s Drug Price Ultimatum? - Morningstar

Aug 07, 2025

Aug 06, 2025

Global Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.

Aug 06, 2025

Jul 31, 2025

Sustainable dividends from European stocks poised to benefit from the tariff wars - The Globe and Mail

Jul 31, 2025

Jul 29, 2025

INCY's Q2 Earnings & Revenues Beat Estimates On Higher Product Sales - Barchart.com

Jul 29, 2025

Jul 25, 2025

NVS’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jul 25, 2025

Jul 18, 2025

Novartis Holds a Strong Branded Drug Portfolio, Supporting Steady Long-Term Growth - Morningstar

Jul 18, 2025

Jul 17, 2025

Novartis Beats On Q2 Earnings And Sales, CFO Retires, Stock Down - Barchart.com

Jul 17, 2025

Jul 17, 2025

Novartis ADR earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria

Jul 17, 2025

Jul 15, 2025

Will Key Drugs Maintain Momentum For Novartis In Q2 Earnings? - Barchart.com

Jul 15, 2025

Jul 10, 2025

Novartis and the pan-Canadian Pharmaceutical Alliance achieve milestone agreement on Cosentyx® for hidradenitis suppurativa (HS) - Barchart.com

Jul 10, 2025

Jul 03, 2025

Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study - TradingView

Jul 03, 2025

Jul 01, 2025

Incyte Gains 9.2% In Three Months: Buy, Hold Or Sell The Stock? - Barchart.com

Jul 01, 2025

Jun 16, 2025

5 Large Drug Stocks That Are Poised To Ride On Sector Recovery - Barchart.com

Jun 16, 2025

Jun 11, 2025

NVO Stock Gains After Parvus Asset Management Builds Stake - Barchart.com

Jun 11, 2025

Jun 10, 2025

The Novartis Oncology Young Canadian Investigator Awards (NOYCIA) returns for its 22nd year at ASCO 2025 - Barchart.com

Jun 10, 2025

Jun 03, 2025

Bristol Myers Collaborates With BNTX For Oncology Candidate - Barchart.com

Jun 03, 2025

May 29, 2025

Penicillin Market Research Report 2025 - GlobeNewswire Inc.

May 29, 2025

May 28, 2025

Why Value Investing Has Worked Better Outside the US - Morningstar

May 28, 2025

May 26, 2025

Which Industries are shaken when Trump's tariff stick swings towards the EU? - 富途牛牛

May 26, 2025

May 22, 2025

Regeneron Initial Data On Multiple Myeloma Drug Encouraging - Barchart.com

May 22, 2025

May 21, 2025

10 International Dividend Aristocrats With Exceptional Dividend Growth Histories - Sure Dividend

May 21, 2025

May 19, 2025

Bybit Gold & FX now supports stock trading: Explore new markets! - Bybit Announcement

May 19, 2025

May 15, 2025

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug - Yahoo Finance

May 15, 2025

May 14, 2025

Novartis Canada extends Health Equity Initiative effort, fueling innovation and impact for second year - Barchart.com

May 14, 2025

May 02, 2025

NVS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

May 02, 2025

Apr 29, 2025

Novartis Earnings: Strong First-Quarter Supports Increased Full-Year Guidance - Morningstar

Apr 29, 2025

Apr 29, 2025

Novartis ADR earnings beat by $0.20, revenue topped estimates - Investing.com

Apr 29, 2025

Apr 29, 2025

Novartis Holds a Strong Branded Drug Portfolio Supporting Steady Long-Term Growth - Morningstar

Apr 29, 2025

Apr 29, 2025

Novartis Beats On Q1 Earnings And Sales, Raises Guidance, Stock Up - Barchart.com

Apr 29, 2025